Sales of Johnson & Johnson’s oncology drugs jumped nearly 19% in the third quarter, driven by cancer treatment Darzalex which ...

Archimed has purchased FIM Medical. Based in Lyon, France, FIM Medical provides vision, hearing, and respiratory care products, using proprietary technology in both its medical devices and software.

Despite the topline growth, J&J’s net earnings fell 37.5% to $2.6 billion, down from $4.3 billion in Q3 2023. Johnson & ...

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key ...

Wales-based biotech company Antiverse has raised $4.6 million in seed funding. AI and biotech startups are continuing to ...

Johnson & Johnson's Q3 results exceeded expectations, with 26.5% year-over-year growth in the cardiovascular market and a 5.4 ...

Johnson & Johnson shares initially rose Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance. However, the stock pulled back and was down ...

To support the company's growth, Non-Executive Director Chris Hand was appointed chair on October 8, to lead Abingdon's operations whilst Chief Executive Officer Chris Yates leads the company's USA ...

Johnson & Johnson (NYSE:JNJ) lowered its full-year earnings outlook on Tuesday despite posting better-than-expected ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on third-quarter financial results and a surgical ...

Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company's exclusive sales and marketing partner for AmnioWrap2®</p ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.